division of infectious diseases

Dooley to lead Division of Infectious Diseases

Kelly Dooley, MD, PhD, MPH, has been appointed professor and Addison B. Scoville Jr. Chair in Medicine and director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center, effective Sept. 12.

Rebecca (Ribka) Berhanu, MD

New Clinician Spotlight: Rebecca (Ribka) Berhanu

Rebecca Berhanu, MD, assistant professor of Medicine, has joined Vanderbilt’s Division of Infectious Diseases as a clinician and researcher.

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.

Invasive strep can defy zinc toxicity

Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.

H. pylori, lipid loss and stomach cancer

H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered.

1 2 3 4 5